Jiarou Wang

422 total citations
15 papers, 268 citations indexed

About

Jiarou Wang is a scholar working on Complementary and alternative medicine, Immunology and Oncology. According to data from OpenAlex, Jiarou Wang has authored 15 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Complementary and alternative medicine, 6 papers in Immunology and 4 papers in Oncology. Recurrent topics in Jiarou Wang's work include Traditional Chinese Medicine Analysis (6 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Lipid metabolism and disorders (2 papers). Jiarou Wang is often cited by papers focused on Traditional Chinese Medicine Analysis (6 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Lipid metabolism and disorders (2 papers). Jiarou Wang collaborates with scholars based in China, Singapore and Russia. Jiarou Wang's co-authors include Min Du, Sijin Li, Ping Liu, Yifan Zhang, Yiru Wang, Yan Sun, Yanru Yu, Fengjie Zheng, Yuhan Sheng and Yuhang Li and has published in prestigious journals such as PLoS ONE, Journal of Ethnopharmacology and Theranostics.

In The Last Decade

Jiarou Wang

14 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiarou Wang China 9 89 48 47 41 32 15 268
Ken Tsuboi Japan 10 154 1.7× 54 1.1× 94 2.0× 23 0.6× 33 1.0× 28 404
Xiaolin Liu China 8 158 1.8× 32 0.7× 34 0.7× 31 0.8× 27 0.8× 18 308
Ling Lu China 9 167 1.9× 47 1.0× 26 0.6× 24 0.6× 21 0.7× 17 357
Stavros P. Papadakos Greece 12 182 2.0× 56 1.2× 66 1.4× 46 1.1× 16 0.5× 43 417
Zhenqiang You China 11 187 2.1× 42 0.9× 33 0.7× 31 0.8× 68 2.1× 19 379
Liqun Ren China 12 133 1.5× 22 0.5× 44 0.9× 33 0.8× 21 0.7× 20 327
Fu-Shun Hsu Taiwan 10 118 1.3× 21 0.4× 55 1.2× 43 1.0× 15 0.5× 22 278
Kyoung Jin Nho South Korea 13 187 2.1× 26 0.5× 32 0.7× 12 0.3× 52 1.6× 21 353

Countries citing papers authored by Jiarou Wang

Since Specialization
Citations

This map shows the geographic impact of Jiarou Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiarou Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiarou Wang more than expected).

Fields of papers citing papers by Jiarou Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiarou Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiarou Wang. The network helps show where Jiarou Wang may publish in the future.

Co-authorship network of co-authors of Jiarou Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiarou Wang. A scholar is included among the top collaborators of Jiarou Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiarou Wang. Jiarou Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wang, Jiarou, Xuejun Wen, Huifeng Guo, et al.. (2025). Dansylated Amino Acid–Modified Long-Acting PSMA Derivatives68Ga/177Lu-LNC1011 as Prostate Cancer Theranostics. Journal of Nuclear Medicine. 66(5). 739–747.
2.
Zhang, Yifan, et al.. (2025). Tanshinone IIA alleviate atherosclerosis and hepatic steatosis via down-regulation of MAPKs/NF-κB signaling pathway. International Immunopharmacology. 152. 114465–114465. 5 indexed citations
3.
4.
Kang, Weiming, Zhen Liu, Linlin Li, et al.. (2024). Head-to-Head Comparison of [68Ga]Ga-NOTA-RM26 and [18F]FDG PET/CT in Patients with Gastrointestinal Stromal Tumors: A Prospective Study. Journal of Nuclear Medicine. 66(2). 201–206. 8 indexed citations
5.
Du, Min, et al.. (2023). Pharmacological effects and mechanisms of paeonol on antitumor and prevention of side effects of cancer therapy. Frontiers in Pharmacology. 14. 1194861–1194861. 14 indexed citations
6.
Wang, Jiarou, Tianzhi Zhao, Naixin Liang, et al.. (2023). Dual targeting PET tracer [68Ga]Ga-FAPI-RGD in patients with lung neoplasms: a pilot exploratory study. Theranostics. 13(9). 2979–2992. 23 indexed citations
7.
Sheng, Yuhan, Yang Tang, Yanru Yu, et al.. (2023). Catechins: Protective mechanism of antioxidant stress in atherosclerosis. Frontiers in Pharmacology. 14. 1144878–1144878. 63 indexed citations
8.
Li, Sijin, et al.. (2023). Mechanism of Tao Hong Decoction in the treatment of atherosclerosis based on network pharmacology and experimental validation. Frontiers in Cardiovascular Medicine. 10. 1111475–1111475. 3 indexed citations
9.
Wang, Jiarou, et al.. (2023). Tanshinone IIA alleviates atherosclerosis in LDLR−/− mice by regulating efferocytosis of macrophages. Frontiers in Pharmacology. 14. 1233709–1233709. 13 indexed citations
10.
Wang, Guochang, Linlin Li, Jiarou Wang, et al.. (2023). Head-to-head comparison of [68Ga]Ga-P16-093 and 2-[18F]FDG PET/CT in patients with clear cell renal cell carcinoma: a pilot study. European Journal of Nuclear Medicine and Molecular Imaging. 50(5). 1499–1509. 21 indexed citations
11.
Zhang, Shujing, Jiarou Wang, Yang Tang, et al.. (2023). Shuyu decoction exhibits anti-fatigue properties via alleviating exercise-induced immune dysfunction. Journal of Ethnopharmacology. 319(Pt 2). 117259–117259. 1 indexed citations
12.
13.
Li, Sijin, et al.. (2022). The role and mechanism of tetramethylpyrazine for atherosclerosis in animal models: A systematic review and meta-analysis. PLoS ONE. 17(5). e0267968–e0267968. 8 indexed citations
14.
Zhang, Yifan, et al.. (2022). Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR−/− Mice. Frontiers in Pharmacology. 13. 828161–828161. 21 indexed citations
15.
Zhang, Yifan, Min Du, Sijin Li, et al.. (2022). Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease. Journal of Translational Medicine. 20(1). 399–399. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ken Tsuboi Breakdown of academic impact, for papers by Xiaolin Liu Breakdown of academic impact, for papers by Ling Lu Breakdown of academic impact, for papers by Stavros P. Papadakos Breakdown of academic impact, for papers by Zhenqiang You Breakdown of academic impact, for papers by Liqun Ren Breakdown of academic impact, for papers by Fu-Shun Hsu Breakdown of academic impact, for papers by Kyoung Jin Nho
Rankless by CCL
2026